Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 148

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 148
---
ended and Restated 2013 Omnibus Incentive Plan of the Company, as amended, effective as of June 19, 2020 (15)10.1K†*2013 Amended and Restated Omnibus Incentive Plan of the Company, as amended, Form of Restricted Stock Unit Agreement for Officers (6)10.1L†*2013 Amended and Restated Omnibus Incentive Plan of the Company, as amended, Form of Restricted Stock Unit Agreement for Directors (6)10.2*  2019 Incentive Plan of the Company for Non-Employee Service Providers, effective as of June 12, 2019 (9)10.3†*  Form of Continuing Employment Agreement (2019) (8)10.4†*Employment Agreement, dated January 1, 2020, by and between the Company and Helen Sabzevari, Ph.D. (10)10.5†*Executive Chairman Compensation Arrangement, by and between the Company and Randal J. Kirk (17)10.6*Securities Issuance Agreement by and among the Company, The University of Texas System Board of Regents on behalf of The University of Texas MD Anderson Cancer Center dated as of January 13, 2015 (1)10.7†*Precigen, Inc. 2023 Omnibus Incentive Plan (10)10.8†*Form of Restricted Stock Unit Agreement under the 2023 Omnibus Incentive Plan (19)10.9†**Form of Incentive Stock Option Agreement under the 2023 Omnibus Incentive Plan (19)10.10†**Form of Continuing Employment Agreement  (19)10.11†*Form of Performance Stock Unit Agreement under the 2023 Omnibus Incentive Plan (17)10.12*Securities Purchase Agreement, dated December 27, 2024 between Precigen Inc. and the Investors party thereto  (18)10.13*Registration Rights Agreement, dated December 30, 2024 between Precigen Inc. and the Investors party thereto (18)10.14*Form of Common Stock Purchase Warrant (18)10.15††Product Commercialization Agreement with EVERSANA Life Science Services, LLC, dated March 19, 202519.1 Insider Trading Policy21.1 List of Subsidiaries of Precigen, Inc.23.1